Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Rev Lett ; 129(21): 217202, 2022 Nov 18.
Article in English | MEDLINE | ID: mdl-36461963

ABSTRACT

Yb_{2}Ti_{2}O_{7} is a celebrated example of a pyrochlore magnet with highly frustrated, anisotropic exchange interactions. To date, attention has largely focused on its unusual, static properties, many of which can be understood as coming from the competition between different types of magnetic order. Here we use inelastic neutron scattering with exceptionally high energy resolution to explore the dynamical properties of Yb_{2}Ti_{2}O_{7}. We find that spin correlations exhibit dynamical scaling, analogous to behavior found near to a quantum critical point. We show that the observed scaling collapse can be explained within a phenomenological theory of multiple-phase competition, and confirm that a scaling collapse is also seen in semiclassical simulations of a microscopic model of Yb_{2}Ti_{2}O_{7}. These results suggest that dynamical scaling may be general to systems with competing ground states.

2.
Pathog Immun ; 4(1): 1-20, 2019.
Article in English | MEDLINE | ID: mdl-30993250

ABSTRACT

BACKGROUND: Vaccination with the Merck human adenovirus serotype-5 (HAdV-5) vectored HIV-1 subtype B gag/pol/nef vaccine was unexpectedly associated with enhanced susceptibility to HIV-1 infection in uncircumcised HAdV-5 seropositive men. It has been hypothesized that vaccination may have resulted in activated CD4+ T lymphocytes trafficking to mucosal sites thereby increasing targets for HIV infection. We have previously shown that AdV-vector vacci-nation in rhesus macaques resulted in an increase in the frequency of activated mucosal CD4+ T cells. However, whether this increase in activation is sufficient to increase susceptibility to HIV/SIV infection is unclear. METHODS: To examine this scenario, we developed a preliminary, proof-of-concept vaccination-challenge model in order to examine vaccine-induced SIV susceptibility in rhesus macaques. Rhesus macaques (n = 10/group) were vaccinated with a simian AdV-7 (SAdV-7)-vector encoding an irrelevant insert (SARS spike) and challenged 5 weeks post-prime in an escalating dosing regimen starting with sub-infectious doses (1:10,000 or 2TCID50) of SIVmac251. RESULTS: In contrast to our previous study, the SAdV-7 vaccine regimen did not induce detectable mucosal CD4+ T cell activation at the time points assessed in animals obtained from a different vendor and housed in a different facility. Within the power of the study, we did not observe significantly increased SIV acquisition in SAdV-7-vaccinated (5/10) versus placebo-vaccinated (3/10) macaques after repeated low-dose intra-rectal SIVmac251 challenge (P < 0.2). CONCLUSIONS: These results lay groundwork for future experiments to assess vaccine-induced SIV susceptibility in rhesus macaques. Further larger-scale studies are necessary to confirm the AdV-vector vaccination associated trend towards increased SIV/HIV acquisition and clarify associated mechanisms.

3.
Article in English | MEDLINE | ID: mdl-28281886

ABSTRACT

A hybrid photo-catalyst, TiO2-ZnO, was synthesized by immobilizing ZnO on commercial TiO2 (aeroxide P25). Activated carbon (AC) was subsequently used to support the hybrid, thus forming a TiO2-ZnO/AC composite catalyst. Fourier transform infrared (FTIR) analysis and scanning electron microscopy integrated with energy-dispersive X-ray spectroscopy (SEM-EDX) investigations revealed successful catalyst synthesis. Optical properties of the hybrid determined from photoluminescence (PL) and Ultraviolet-visible (UV-vis) spectroscopy confirmed a restrained recombination of electron-hole pairs and reduced energy band gap due to a successful heterojunction formation. The prepared catalysts were used to photodecolorise vinasse in a 12-W UVC batch photoreactor. TiO2-ZnO had improved photocatalytic activity compared with TiO2 and ZnO separately. On supporting the hybrid onto AC, both adsorption and photocatalytic activities were further enhanced with improved overall color removal of 86% from 68%. Photodecolorisation followed the pseudo-first-order reaction model with the rate constant ([Formula: see text]) observed decreasing from 0.0701 to 0.0436 min-1 on increasing the initial concentration from 5,000 to 14,000 ppm. The UV process was found to be 33-fold less energy intensive for color reduction as compared to total organic carbon (TOC) reduction. Formation of nitrates during the photodecolorisation process was attributed to the mineralization of nitrogen heteroatoms in the color-causing melanoidin compounds.


Subject(s)
Charcoal/chemistry , Light , Polymers/analysis , Titanium/chemistry , Waste Disposal, Fluid/methods , Zinc Oxide/chemistry , Adsorption , Catalysis , Food Industry , Industrial Waste/analysis , Industrial Waste/prevention & control , Microscopy, Electron, Scanning , Particle Size , Polymers/chemistry , Polymers/radiation effects , Spectrometry, X-Ray Emission , Surface Properties , Titanium/radiation effects , X-Ray Diffraction , X-Rays , Zinc Oxide/radiation effects
4.
Immunity ; 45(3): 656-668, 2016 09 20.
Article in English | MEDLINE | ID: mdl-27653601

ABSTRACT

Infection with HIV persists despite suppressive antiretroviral therapy (ART), and treatment interruption results in rapid viral rebound. Antibody-mediated CD8(+) lymphocyte depletion in simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) shows that these cells contribute to viral control in untreated animals. However, the contribution of CD8(+) lymphocytes to maintaining viral suppression under ART remains unknown. Here, we have shown that in SIV-infected RMs treated with short-term (i.e., 8-32 week) ART, depletion of CD8(+) lymphocytes resulted in increased plasma viremia in all animals and that repopulation of CD8(+) T cells was associated with prompt reestablishment of virus control. Although the number of SIV-DNA-positive cells remained unchanged after CD8 depletion and reconstitution, the frequency of SIV-infected CD4(+) T cells before depletion positively correlated with both the peak and area under the curve of viremia after depletion. These results suggest a role for CD8(+) T cells in controlling viral production during ART, thus providing a rationale for exploring immunotherapeutic approaches in ART-treated HIV-infected individuals.


Subject(s)
Anti-Retroviral Agents/pharmacology , CD8-Positive T-Lymphocytes/immunology , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/immunology , Animals , Antibodies, Viral/immunology , Antiretroviral Therapy, Highly Active/methods , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , Female , Lymphocyte Depletion/methods , Macaca mulatta , Male , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/drug effects , Viral Load/drug effects , Viral Load/immunology , Viremia/drug therapy , Viremia/immunology , Viremia/virology , Virus Replication/drug effects , Virus Replication/immunology
5.
J Virol ; 89(17): 8677-86, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26063417

ABSTRACT

UNLABELLED: Numerous studies have demonstrated that CD8(+) T lymphocytes suppress virus replication during human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection. However, the mechanisms underlying this activity of T cells remain incompletely understood. Here, we conducted CD8(+) T lymphocyte depletion in 15 rhesus macaques (RMs) infected intravenously (i.v.) with SIVmac239. At day 70 postinfection, the animals (10 progressors with high viremia and 5 controllers with low viremia) were CD8 depleted by i.v. administration of the antibody M-T807R1. As expected, CD8 depletion resulted in increased virus replication, more prominently in controllers than progressors, which correlated inversely with predepletion viremia. Of note, the feature of CD8(+) T lymphocyte predepletion that correlated best with the increase in viremia postdepletion was the level of CD8(+) T-bet(+) lymphocytes. We next found that CD8 depletion resulted in a homogenous increase of SIV RNA in superficial and mesenteric lymph nodes, spleen, and the gastrointestinal tract of both controllers and progressors. Interestingly, the level of SIV DNA increased postdepletion in both CD4(+) central memory T lymphocytes (TCM) and CD4(+) effector memory T lymphocytes (TEM) in progressor RMs but decreased in the CD4(+) TCM of 4 out of 5 controllers. Finally, we found that CD8 depletion is associated with a greater increase in CD4(+) T lymphocyte activation (measured by Ki-67 expression) in controllers than in progressors. Overall, these data reveal a differential impact of CD8(+) T lymphocyte depletion between controller and progressor SIV-infected RMs, emphasizing the complexity of the in vivo antiviral role of CD8(+) T lymphocytes. IMPORTANCE: In this study, we further dissect the impact of CD8(+) T lymphocytes on HIV/SIV replication during SIV infection. CD8(+) T lymphocyte depletion leads to a relatively homogenous increase in viral replication in peripheral blood and tissues. CD8(+) T lymphocyte depletion resulted in a more prominent increase in viral loads and CD4(+) T lymphocyte activation in controllers than in progressors. Interestingly, we found T-bet expression on CD8(+) T lymphocytes to be the best predictor of viral load increase following depletion. The levels of SIV DNA increase postdepletion in both CD4(+) TCM and TEM in progressor RMs but decrease in the CD4(+) TCM of controllers. The findings described in this study provide key insights into the differential functions of CD8(+) T lymphocytes in controller and progressor RMs.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Lymphocyte Activation/immunology , Lymphocyte Depletion , Simian Immunodeficiency Virus/immunology , Animals , DNA, Viral/genetics , Female , Gastrointestinal Tract/virology , Immunologic Memory/immunology , Lymph Nodes/virology , Macaca mulatta , RNA, Viral/genetics , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Spleen/virology , Viral Load , Viremia/veterinary , Viremia/virology , Virus Replication/immunology
6.
Blood ; 119(24): 5750-7, 2012 Jun 14.
Article in English | MEDLINE | ID: mdl-22550346

ABSTRACT

A key feature differentiating nonpathogenic SIV infection of sooty mangabeys (SMs) from pathogenic HIV/SIV infections is the rapid resolution of type I IFN (IFN-I) responses and IFN-stimulated gene expression during the acute-to-chronic phase transition and the establishment of an immune quiescent state that persists throughout the chronic infection. We hypothesized that low levels of IFN-I signaling may help to prevent chronic immune activation and disease progression in SIV-infected SMs. To assess the effects of IFN-I signaling in this setting, in the present study, we administered recombinant rhesus macaque IFNα2-IgFc (rmIFNα2) to 8 naturally SIV-infected SMs weekly for 16 weeks. Gene-expression profiling revealed a strong up-regulation of IFN-stimulated genes in the blood of treated animals, confirming the reagent's bioactivity. Interestingly, we observed an approximately 1-log decrease in viral load that persisted through day 35 of treatment. Flow cytometric analysis of lymphocytes in the blood, lymph nodes, and rectal biopsies did not reveal a significant decline of CD4(+) T cells, a robust increase in lymphocyte activation, or change in the level of SIV-specific CD8(+) T cells. The results of the present study indicate that administration of type I IFNs in SIV-infected SMs induces a significant anti-viral effect that is not associated with a detectable increase in chronic immune activation.


Subject(s)
Cercocebus atys/virology , Interferon Type I/agonists , Lymphocyte Activation/drug effects , Recombinant Proteins/pharmacology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/physiology , Virus Replication/drug effects , Animals , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Cell Proliferation/drug effects , Cercocebus atys/blood , Cercocebus atys/immunology , Gene Expression Regulation/drug effects , Humans , Interferon Type I/administration & dosage , Interferon Type I/pharmacology , Lymphocyte Depletion , Macaca mulatta/immunology , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Simian Acquired Immunodeficiency Syndrome/blood , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/drug effects , Species Specificity , Viral Load/drug effects , Viremia/blood , Viremia/immunology , Viremia/virology
8.
Urology ; 29(4): 423-5, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3564217

ABSTRACT

Ectopic papillae may represent as filling defects in the renal pelvis. We report 1 case which resulted in a nephrectomy. A review of the literature is given and a diagnostic plan suggested.


Subject(s)
Choristoma/pathology , Kidney Medulla , Kidney Neoplasms/pathology , Choristoma/diagnostic imaging , Female , Humans , Kidney Neoplasms/diagnostic imaging , Kidney Pelvis/diagnostic imaging , Middle Aged , Radiography
9.
J Urol ; 137(3): 527-8, 1987 Mar.
Article in English | MEDLINE | ID: mdl-3493354

ABSTRACT

Although von Willebrand's disease is an unusual cause of gross hematuria in children, it is readily treatable with fresh frozen plasma or cryoprecipitate. We present 2 cases of recurrent, painless gross hematuria owing to this congenital factor VIII deficiency disorder. In each case the diagnosis was suggested first by the finding of a prolonged bleeding time. We suggest that the bleeding time determination be included as part of the screening hemostatic studies used in the evaluation of unexplained hematuria.


Subject(s)
Hematuria/etiology , von Willebrand Diseases/complications , Bleeding Time , Child , Humans , Male , von Willebrand Diseases/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...